4579.T
Price:
$1129
Market Cap:
$27.61B
RaQualia Pharma Inc. engages in the research and development of pharmaceutical compounds worldwide. Its human products portfolio includes tegoprazan for gastroesophageal reflux disease, which is in phase 1 clinical trial in the United States; and grapiprant for pain management, which is in phase II clinical trial in the United States and phase I clinical trial in China, as well as in phase I clinical trial in China and the United States to treat cancer. The company also provides veterinary products such as, grapiprant for osteoarthritis in dogs; ghrelin receptor agonist to treat cancer-related anorexia/cachexia syndrome, and constipation resulting from spinal cord injury; and ELURA, a drug f...[Read more]
Industry
Biotechnology
IPO Date
2011-07-20
Stock Exchange
JPX
Ticker
4579.T
According to RaQualia Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 27.39B. This represents a change of 164.14% compared to the average of 10.37B of the last 4 quarters.
The mean historical Enterprise Value of RaQualia Pharma Inc. over the last ten years is 18.30B. The current 27.39B Enterprise Value has changed 14.86% with respect to the historical average. Over the past ten years (40 quarters), 4579.T's Enterprise Value was at its highest in in the December 2017 quarter at 45.02B. The Enterprise Value was at its lowest in in the December 2015 quarter at 4.27B.
Average
18.30B
Median
19.94B
Minimum
3.51B
Maximum
43.38B
Discovering the peaks and valleys of RaQualia Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 622.47%
Maximum Annual Enterprise Value = 43.38B
Minimum Annual Increase = -53.27%
Minimum Annual Enterprise Value = 3.51B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 8.62B | -25.14% |
| 2023 | 11.52B | -48.54% |
| 2022 | 22.38B | 0.40% |
| 2021 | 22.29B | 13.73% |
| 2020 | 19.60B | -22.94% |
| 2019 | 25.44B | 25.50% |
| 2018 | 20.27B | -53.27% |
| 2017 | 43.38B | 622.47% |
| 2016 | 6.00B | 71.05% |
| 2015 | 3.51B | -20.00% |
The current Enterprise Value of RaQualia Pharma Inc. (4579.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
14.17B
5-year avg
16.88B
10-year avg
18.30B
RaQualia Pharma Inc.’s Enterprise Value is greater than NANO MRNA Co.,Ltd. (9.42B), greater than MediciNova, Inc. (42.55M), greater than CellSeed Inc. (7.84B), greater than Japan Medical Dynamic Marketing, Inc. (14.42B), greater than Kidswell Bio Corporation (9.47B), greater than CanBas Co., Ltd. (12.74B), greater than Stella Pharma Corporation (6.42B), greater than Techno Medica Co., Ltd. (5.59B), greater than Daiken Medical Co., Ltd. (11.94B), greater than Chiome Bioscience Inc. (6.34B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 9.42B | $10.48B | |
| 42.55M | $11.53B | |
| 7.84B | $9.36B | |
| 14.42B | $12.46B | |
| 9.47B | $10.76B | |
| 12.74B | $15.57B | |
| 6.42B | $8.54B | |
| 5.59B | $14.26B | |
| 11.94B | $12.64B | |
| 6.34B | $7.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RaQualia Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RaQualia Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is RaQualia Pharma Inc.'s Enterprise Value?
What is the highest Enterprise Value for RaQualia Pharma Inc. (4579.T)?
What is the 3-year average Enterprise Value for RaQualia Pharma Inc. (4579.T)?
What is the 5-year average Enterprise Value for RaQualia Pharma Inc. (4579.T)?
How does the current Enterprise Value for RaQualia Pharma Inc. (4579.T) compare to its historical average?